GALT
Galectin Therapeutics Inc
3.60$
-3.7%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | -100.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -100.0% | – | – | – | -100.0% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +0.0% | +0.0% | +10.0% | -9.1% | -30.0% | – | – | +300.0% | – | – | +12.5% | +0.0% | +0.0% | +0.0% | +11.1% | +0.0% | -80.0% | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -200.0% | – | – | |
| – | +4.4% | +9.9% | -8.7% | +1.7% | -71.4% | +129.3% | -35.8% | +2.0% | -20.8% | -45.8% | +135.6% | -1.2% | +152.6% | -43.5% | +118.3% | +2.1% | +33.3% | -23.1% | +31.7% | +2.5% | -11.4% | +37.6% | +0.2% | -18.3% | +36.5% | -2.3% | -16.2% | +4.9% | +6.4% | -2.1% | +21.8% | -22.6% | +46.3% | -41.6% | -49.7% | -19.9% | -26.0% | +15.4% | -4.3% | – | |
| – | -6.6% | +0.7% | -8.9% | -14.9% | +50.5% | +37.1% | +21.4% | -48.5% | +52.6% | -4.0% | -13.0% | -9.2% | +2.4% | +3.4% | -1.3% | -19.4% | +27.5% | -2.9% | +22.9% | -6.4% | -3.8% | +19.6% | -15.4% | -4.0% | +6.7% | -5.1% | +5.8% | -12.1% | -7.0% | +19.6% | -7.3% | -0.5% | -10.3% | +7.1% | -3.4% | +16.3% | -9.8% | +28.9% | +0.1% | – | |
| – | +1.4% | +7.5% | -8.7% | -2.2% | -46.2% | +76.1% | -10.0% | -28.7% | +11.4% | -20.7% | +27.6% | -5.2% | +81.2% | -30.9% | +70.3% | -2.9% | +32.2% | -19.3% | +29.7% | +0.6% | -9.9% | +33.8% | -2.7% | -15.9% | +30.9% | -2.7% | -12.9% | +1.8% | +4.3% | +0.9% | +17.0% | -19.7% | +37.1% | -36.5% | -41.4% | -9.2% | -19.8% | +21.2% | -2.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -100.0% | – | – | – | +600.0% | +1.2% | +2.4% | -8.0% | -72.5% | -4.5% | +4.8% | +0.0% | +0.0% | -4.5% | +4.8% | +0.0% | +0.0% | +286.4% | +30.6% | +145.0% | -16.5% | +0.9% | +17.5% | +14.5% | +49.4% | +41.3% | +28.5% | +1.4% | +24.2% | +20.6% | +17.7% | +15.5% | +1.1% | +4.7% | -0.3% | +6.5% | +2.5% | +0.8% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | -100.0% | – | – | – | – | +207.1% | +134.9% | -27.7% | -31.5% | -82.0% | -44.4% | +156,510.7% | -100.0% | +8,400.0% | +30.6% | +144.1% | -101.1% | – | – | +4,014.9% | -96.1% | -13.4% | +25.4% | -371.9% | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.